Human parvovirus B19. Recognizes amino acids 446-466 of VP2. Antibody inhibits haemagglutination.
Immunogen
B-19 virus purified from an acute serum specimen from a child with aplastic crisis (Anderson, 1986).
Anwendung
Research Category Infektionskrankheiten
Research Sub Category Virale Infektionskrankheiten
Immunoassay.
Immunocytochemistry
Optimal working dilutions must be determined by end user.
This Anti-Parvovirus B19 Antibody, clone 521-5D is validated for use in ELISA, IC, IH, IH(P) for the detection of Parvovirus B19.
Physikalische Form
Format: Purified
Purified immunoglobulin. In 0.02M PB and 0.25M NaCl pH=7.6 with 0.1% NaN3 as a preservative.
Lagerung und Haltbarkeit
Maintain at 2-8°C in undiluted aliquots for up to 12 months
Sonstige Hinweise
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Rechtliche Hinweise
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Haftungsausschluss
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Lagerklassenschlüssel
10 - Combustible liquids
WGK
WGK 2
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
BJOG : an international journal of obstetrics and gynaecology, 107(4), 476-480 (2000-04-12)
To identify the presence of parvovirus B19 infection as a possible cause of fetal loss in the third trimester. Prospective study of women experiencing third-trimester intrauterine fetal death (IUFD). All cases of IUFD at Danderyd Hospital from 1992 to 1998.
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
